Prediction of boron concentrations in blood from patients on boron neutron capture therapy

被引:0
|
作者
Shibata, Y
Matsumura, A [1 ]
Yamamoto, T
Akutsu, H
Yasuda, S
Nakai, K
Nose, T
Yamamoto, K
Kumada, H
Hori, N
Ohtake, S
机构
[1] Univ Tsukuba, Dept Neurosurg, Tsukuba, Ibaraki 3058575, Japan
[2] Japan Atom Energy Res Inst, Tokai, Ibaraki 3191195, Japan
关键词
boron neutron capture therapy; BSH; glioblastoma; prompt gamma ray analysis; radiation therapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In boron neutron capture therapy, blood boron concentration is the key factor to calculate radiation dose, however, blood sampling is difficult during neutron irradiation. Materials and Methods: The prediction of blood boron concentrations for BNCT treatment planning has been prospectively investigated using patient data obtained at first craniotomy after the infusion of a low dose of sodium undecahydroclosododecaborate. Results: The boron biodistribution data showed a biexponential pharmacokinetic profile. If the final boron concentration at 6 or 9 hours after the end of the infusion is within the 95% confidence interval of the prediction, direct prediction from biexponential fit will reduce the error of blood boron concentrations during irradiation to around 6%. Conclusion: Actual boron concentrations during BNCT were reasonably and accurately predictable from the test data.
引用
收藏
页码:5231 / 5235
页数:5
相关论文
共 50 条
  • [1] Boron Neutron Capture Therapy: Microdosimetry at Different Boron Concentrations
    Conte, Valeria
    Bianchi, Anna
    Selva, Anna
    APPLIED SCIENCES-BASEL, 2024, 14 (01):
  • [2] Boron neutron capture therapy for glioblastoma: improvement of boron biodistribution by hyaluronidase
    Haselsberger, K
    Radner, H
    Pendl, C
    CANCER LETTERS, 1998, 131 (01) : 109 - 111
  • [3] Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients
    Kawabata, Shinji
    Miyatake, Shin-Ichi
    Nonoguchi, Naosuke
    Hiramatsu, Ry.
    Iida, Kyoko
    Miyata, Shiro
    Yokoyama, Kunio
    Doi, Atsushi
    Kuroda, Yuzo
    Kuroiwa, Toshihiko
    Michiue, Hiroyuki
    Kumada, Hiroaki
    Kirihata, Mitsunori
    Imahori, Yoshio
    Maruhashi, Akira
    Sakurai, Yoshinori
    Suzuki, Minoru
    Masunaga, Shin-Ichiro
    Ono, Koji
    APPLIED RADIATION AND ISOTOPES, 2009, 67 (7-8) : S15 - S18
  • [4] Boron delivery agents for boron neutron capture therapy
    Li, Fenglin
    Luo, Zhifu
    CHINESE SCIENCE BULLETIN-CHINESE, 2022, 67 (14): : 1517 - 1531
  • [5] Induced radioactivity in the blood of cancer patients following Boron Neutron Capture Therapy
    Fujiwara, Keiko
    Kinashi, Yuko
    Takahashi, Tomoyuki
    Yashima, Hiroshi
    Kurihara, Kouta
    Sakurai, Yoshinori
    Tanaka, Hiroki
    Ono, Koji
    Takahashi, Sentaro
    JOURNAL OF RADIATION RESEARCH, 2013, 54 (04) : 769 - 774
  • [6] Boron neutron capture therapy for brain tumors
    Yamamoto, Tetsuya
    Tsuboi, Koji
    Nakai, Kei
    Kumada, Hiroaki
    Sakurai, Hideyuki
    Matsumura, Akira
    TRANSLATIONAL CANCER RESEARCH, 2013, 2 (02) : 80 - 86
  • [7] Boron neutron capture therapy - Clinical brain tumor studies
    Nakagawa, Y
    Hatanaka, H
    JOURNAL OF NEURO-ONCOLOGY, 1997, 33 (1-2) : 105 - 115
  • [8] Boron neutron capture therapy: Clinical brain tumor studies
    Yoshinobu Nakagawa
    Hiroshi Hatanaka†
    Journal of Neuro-Oncology, 1997, 33 : 105 - 115
  • [9] Boron and gadolinium neutron capture therapy
    Salt, C
    Lennox, AJ
    Takagaki, M
    Maguire, JA
    Hosmane, NS
    RUSSIAN CHEMICAL BULLETIN, 2004, 53 (09) : 1871 - 1888
  • [10] Boron and gadolinium neutron capture therapy
    C. Salt
    A. J. Lennox
    M. Takagaki
    J. A. Maguire
    N. S. Hosmane
    Russian Chemical Bulletin, 2004, 53 : 1871 - 1888